Biosimilar Contract Manufacturing Market Size, Share & Trends Report

Biosimilar Contract Manufacturing Market Size, Share & Trends Analysis Report By Production Technology (Mammalian, Non-Mammalian), By Application (Oncology, Blood Disorders), By Product, By Region, And Segment Forecasts, 2022 - 2030

Report ID: GVR-4-68039-970-1
Number of Pages: 275
Format: Electronic (PDF)

Historical Range: 2018 - 2020
Industry: Healthcare

Market Segmentation

Biosimilar Contract Manufacturing Product Outlook (Revenue, USD Billion, 2018 - 2030)
- Recombinant Non-Glycosylated Proteins
- Recombinant Glycosylated Proteins
Biosimilar Contract Manufacturing Production Technology Outlook (Revenue, USD Billion, 2018 - 2030)
- Mammalian
- Non-Mammalian
Biosimilar Contract Manufacturing Application Outlook (Revenue, USD Billion, 2018 - 2030)
- Oncology
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Rheumatoid Arthritis
- Others
Biosimilar Contract Manufacturing Regional Outlook (Revenue, USD Billion, 2018 - 2030)
- North America
  - North America Biosimilar contract manufacturing market, By Product
    - Recombinant Non-Glycosylated Proteins
    - Recombinant Glycosylated Proteins
  - North America Biosimilar contract manufacturing market, By Production technology
    - Mammalian
    - Non-Mammalian
  - North America Biosimilar contract manufacturing market, By Application
    - Oncology
    - Blood Disorders
    - Growth Hormonal Deficiency
    - Rheumatoid Arthritis
    - Chronic and Autoimmune Disorders
    - Others
  - U.S.
    - U.S. Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - U.S. Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - U.S. Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
  - Canada
    - Canada Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - Canada Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - Canada Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
- Europe
  - Europe Biosimilar contract manufacturing market, By Product
    - Recombinant Non-Glycosylated Proteins
    - Recombinant Glycosylated Proteins
  - Europe Biosimilar contract manufacturing market, By Production technology
    - Mammalian
    - Non-Mammalian
  - Europe Biosimilar contract manufacturing market, By Application
    - Oncology
    - Blood Disorders
    - Growth Hormonal Deficiency
    - Rheumatoid Arthritis
    - Chronic and Autoimmune Disorders
    - Others
  - U.K.
    - U.K. Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - U.K. Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - U.K. Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
  - Germany
    - Germany Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - Germany Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - Germany Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
  - France
    - France Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - France Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - France Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
  - Italy
    - Italy Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - Italy Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - Italy Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
  - Spain
    - Spain Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - Spain Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - Spain Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
- Asia Pacific
  - Asia Pacific Biosimilar contract manufacturing market, By Product
    - Recombinant Non-Glycosylated Proteins
    - Recombinant Glycosylated Proteins
  - Asia Pacific Biosimilar contract manufacturing market, By Production technology
    - Mammalian
    - Non-Mammalian
  - Asia Pacific Biosimilar contract manufacturing market, By Application
    - Oncology
    - Blood Disorders
    - Growth Hormonal Deficiency
    - Rheumatoid Arthritis
    - Chronic and Autoimmune Disorders
    - Others
  - Japan
    - Japan Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - Japan Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - Japan Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
  - China
    - China Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - China Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - China Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
  - India
    - India Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - India Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - India Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
  - Australia
    - Australia Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - Australia Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - Australia Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
  - South Korea
    - South Korea Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - South Korea Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - South Korea Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
- Latin America
  - Latin America Biosimilar contract manufacturing market, By Product
    - Recombinant Non-Glycosylated Proteins
    - Recombinant Glycosylated Proteins
  - Latin America Biosimilar contract manufacturing market, By Production technology
    - Mammalian
    - Non-Mammalian
  - Latin America Biosimilar contract manufacturing market, By Application
    - Oncology
    - Blood Disorders
    - Growth Hormonal Deficiency
    - Rheumatoid Arthritis
    - Chronic and Autoimmune Disorders
    - Others
  - Brazil
    - Brazil Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - Brazil Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - Brazil Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
  - Mexico
    - Mexico Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - Mexico Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - Mexico Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
  - Argentina
    - Argentina Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - Argentina Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - Argentina Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
- MEA
  - MEA Biosimilar contract manufacturing market, By Product
    - Recombinant Non-Glycosylated Proteins
    - Recombinant Glycosylated Proteins
  - MEA Biosimilar contract manufacturing market, By Production technology
    - Mammalian
    - Non-Mammalian
  - MEA Biosimilar contract manufacturing market, By Application
    - Oncology
    - Blood Disorders
    - Growth Hormonal Deficiency
    - Rheumatoid Arthritis
    - Chronic and Autoimmune Disorders
    - Others
  - South Africa
    - South Africa Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - South Africa Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - South Africa Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others
  - Saudi Arabia
    - Saudi Arabia Biosimilar contract manufacturing market, By Product
      - Recombinant Non-Glycosylated Proteins
      - Recombinant Glycosylated Proteins
    - Saudi Arabia Biosimilar contract manufacturing market, By Production technology
      - Mammalian
      - Non-Mammalian
    - Saudi Arabia Biosimilar contract manufacturing market, By Application
      - Oncology
      - Blood Disorders
      - Growth Hormonal Deficiency
      - Rheumatoid Arthritis
      - Chronic and Autoimmune Disorders
      - Others

Report Content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s Five Forces analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.